Reinhard Dummer (R Dummer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 95

Top Topics

Convolutional Neural Network

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Journal for immunotherapy of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Meng Wang, Satoshi Fukushima, Yi-Shuan Sheen, Egle Ramelyte, Noel Cruz Pacheco, Chenxu Shi, Shanshan Liu, Ishani Banik, Jamie D Aquino, Martin Sangueza Acosta, Mitchell Paul Levesque, Reinhard Dummer, Jau-Yu Liau, Chia-Yu Chu, A Hunter Shain, Iwei Yeh, Boris C Bastian
The genetic evolution of acral melanoma. Nature communications 15 (1) (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Elias Burri, Joanna Mangana, Phil F Cheng, Alia Schneider, Achim Weber, Reinhard Dummer, Egle Ramelyte
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids. Journal for immunotherapy of cancer 12 (7) (2024)
Elias Burri, Joanna Mangana, Phil F Cheng, Alia Schneider, Achim Weber, Reinhard Dummer, Egle Ramelyte
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids. Journal for immunotherapy of cancer 12 (7) (2024)
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Aedo Lopez Veronica, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie R Tissot, Lana Elias Kandalaft, Raphaël Gottardo, Mikaël J Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, Sergio A Quezada
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma. Science immunology 9 (92) (2024)
Meng Wang, Satoshi Fukushima, Yi-Shuan Sheen, Egle Ramelyte, Noel Cruz Pacheco, Chenxu Shi, Shanshan Liu, Ishani Banik, Jamie D Aquino, Martin Sangueza Acosta, Mitchell Paul Levesque, Reinhard Dummer, Jau-Yu Liau, Chia-Yu Chu, A Hunter Shain, Iwei Yeh, Boris C Bastian
The genetic evolution of acral melanoma. Nature communications 15 (1) (2024)
Elias Burri, Joanna Mangana, Phil F Cheng, Alia Schneider, Achim Weber, Reinhard Dummer, Egle Ramelyte
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids. Journal for immunotherapy of cancer 12 (7) (2024)
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Aedo Lopez Veronica, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie R Tissot, Lana Elias Kandalaft, Raphaël Gottardo, Mikaël J Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, Sergio A Quezada
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma. Science immunology 9 (92) (2024)
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Aedo Lopez Veronica, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie R Tissot, Lana Elias Kandalaft, Raphaël Gottardo, Mikaël J Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, Sergio A Quezada
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma. Science immunology 9 (92) (2024)
Meng Wang, Satoshi Fukushima, Yi-Shuan Sheen, Egle Ramelyte, Noel Cruz Pacheco, Chenxu Shi, Shanshan Liu, Ishani Banik, Jamie D Aquino, Martin Sangueza Acosta, Mitchell Paul Levesque, Reinhard Dummer, Jau-Yu Liau, Chia-Yu Chu, A Hunter Shain, Iwei Yeh, Boris C Bastian
The genetic evolution of acral melanoma. Nature communications 15 (1) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Ramon Staeger, Julia Martínez Gómez, Patrick Turko, Egle Ramelyte, Lukas Kraehenbuehl, Valerio Del Prete, Omar Hasan Ali, Mitchell Paul Levesque, Reinhard Dummer, Mirjam C Nägeli, Joanna Mangana
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland. Cancers 16 (5) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Ramon Staeger, Julia Martínez Gómez, Patrick Turko, Egle Ramelyte, Lukas Kraehenbuehl, Valerio Del Prete, Omar Hasan Ali, Mitchell Paul Levesque, Reinhard Dummer, Mirjam C Nägeli, Joanna Mangana
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland. Cancers 16 (5) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Meng Wang, Satoshi Fukushima, Yi-Shuan Sheen, Egle Ramelyte, Noel Cruz Pacheco, Chenxu Shi, Shanshan Liu, Ishani Banik, Jamie D Aquino, Martin Sangueza Acosta, Mitchell Paul Levesque, Reinhard Dummer, Jau-Yu Liau, Chia-Yu Chu, A Hunter Shain, Iwei Yeh, Boris C Bastian
The genetic evolution of acral melanoma. Nature communications 15 (1) (2024)
Florentia Dimitriou, Phil Fang Cheng, Annalisa Saltari, Katrin Schaper-Gerhardt, Ramon Staeger, Veronika Haunerdinger, Federica Sella, Aizhan Tastanova, Christian Urban, Susanne Dettwiler, Daniela Mihic-Probst, Christian M Matter, Olivier Michielin, Ralf Gutzmer, Georgina V Long, Burkhard Becher, Mitchell Paul Levesque, Reinhard Dummer
A targetable type III immune response with increase of IL-17A expressing CD4 + T cells is associated with immunotherapy-induced toxicity in melanoma. Nature cancer (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
C Gaudy-Marqueste, J J Grob, Claus Garbe, P A Ascierto, S Arron, N Basset-Seguin, A S Bohne, C Lenoir, Reinhard Dummer, Maria-Concetta Fargnoli, A Guminski, A Hauschild, Roland Kaufmann, Aimillios Lallas, V Del Marmol, M Migden, M Penicaud, A Rembielak, A Stratigos, L Tagliaferri, I Zalaudek, A Arance, D Badinand, Paolo Bossi, Amarnath Challapalli, M Clementi, A Di Stefani, C Ferrándiz-Pulido, Roberta Giuffrida, G L Gravina, P Ha, L Heinzerling, S Mallet, A Paradisi, P Mohr, Alfredo Piccerillo, D Rutkowski, P Saiag, P Sollena, Myrto Trakatelli, P Wojcieszek, S S Yom, Enrico Zelin, Ketty Peris, J Malvehy
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler, Luzia Briker, Patrick Turko, Gergely Karsai, Nina Zila, Verena Paulitschke, Phil Fang Cheng, Alexander Leitner, Andrea Bileck, Nicola Zamboni, Anja Irmisch, Zsolt Balazs, Aizhan Tastanova, Susana Pascoal, Pål Johannsen, Rebekka Wegmann, Julien Mena, Alaa Othman, Vasanthi S Viswanathan, Judith Wenzina, Andrea Aloia, Annalisa Saltari, Andreas Dzung, null null, Rudolf Aebersold, Melike Ak, Faisal S Al-Quaddoomi, Silvana I Albert, Jonas Albinus, Ilaria Alborelli, Sonali Andani, Per-Olof Attinger, Marina Bacac, Daniel Baumhoer, Beatrice Beck-Schimmer, Niko Beerenwinkel, Christian Beisel, Lara Bernasconi, Anne Bertolini, Bernd Bodenmiller, Ximena Bonilla, Lars Bosshard, Byron Calgua, Ruben Casanova, Stéphane Chevrier, Natalia Chicherova, Ricardo Coelho, Maya D'Costa, Esther Danenberg, Natalie Davidson, Monica-Andreea Drãgan, Reinhard Dummer, Stefanie Engler, Martin Erkens, Katja Eschbach, Cinzia Esposito, André Fedier, Pedro Ferreira, Joanna Ficek, Anja L Frei, Bruno Frey, Sandra Goetze, Linda Grob, Gabriele Gut, Detlef Günther, Martina Haberecker, Pirmin Haeuptle, Viola Heinzelmann-Schwarz, Sylvia Herter, Rene Holtackers, Tamara Huesser, Alexander Immer, Anja Irmisch, Francis Jacob, Andrea Jacobs, Tim M Jaeger, Katharina Jahn, Alva R James, Philip M Jermann, André Kahles, Abdullah Kahraman, Viktor H Koelzer, Werner Kuebler, Jack Kuipers, Christian P Kunze, Christian Kurzeder, Kjong-Van Lehmann, Mitchell Levesque, Ulrike Lischetti, Sebastian Lugert, Gerd Maass, Markus G Manz, Philipp Markolin, Martin Mehnert, Julien Mena, Julian M Metzler, Nicola Miglino, Emanuela S Milani, Holger Moch, Simone Muenst, Riccardo Murri, Charlotte Ky Ng, Stefan Nicolet, Marta Nowak, Monica Nunez Lopez, Patrick Ga Pedrioli, Lucas Pelkmans, Salvatore Piscuoglio, Michael Prummer, Natalie Rimmer, Mathilde Ritter, Christian Rommel, María L Rosano-González, Gunnar Rätsch, Natascha Santacroce, Jacobo Sarabia Del Castillo, Ramona Schlenker, Petra C Schwalie, Severin Schwan, Tobias Schär, Gabriela Senti, Wenguang Shao, Franziska Singer, Sujana Sivapatham, Berend Snijder, Bettina Sobottka, Vipin T Sreedharan, Stefan Stark, Daniel J Stekhoven, Tanmay Tanna, Alexandre Pa Theocharides, Tinu M Thomas, Markus Tolnay, Vinko Tosevski, Nora C Toussaint, Mustafa A Tuncel, Marina Tusup, Audrey Van Drogen, Marcus Vetter, Tatjana Vlajnic, Sandra Weber, Walter P Weber, Rebekka Wegmann, Michael Weller, Fabian Wendt, Norbert Wey, Andreas Wicki, Mattheus He Wildschut, Bernd Wollscheid, Shuqing Yu, Johanna Ziegler, Marc Zimmermann, Martin Zoche, Gregor Zuend, Michael Krauthammer, Stuart L Schreiber, Thorsten Hornemann, Martin Distel, Berend Snijder, Reinhard Dummer, Mitchell Paul Levesque
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer research (2023)
Dirk Tomsitz, Theresa Ruf, Markus Vincent Heppt, Ramon Staeger, Egle Ramelyte, Reinhard Dummer, Marlene Garzarolli, Friedegund Meier, Eileen Meier, Heike Richly, Tanja Gromke, Jens Thomas Siveke, Cindy Franklin, Kai-Christian Klespe, Cornelia Mauch, Teresa Kilian, Marlene Seegräber, Bastian Schilling, Lars E French, Carola Berking, Lucie Heinzerling
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study. Cancers 15 (13) (2023)
S Steinmann, Carole Guillet, P F Cheng, M P Levesque, Reinhard Dummer, I Kolm, Julia-Tatjana Maul
Identifying the potential origin of mucin in primary cutaneous mucinoses-A retrospective study and analysis using histopathology and multiplex fluorescence staining. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Julia Lehmann, Nicole Caduff, Ewelina Krzywińska, Salome Stierli, Adrian Salas-Bastos, Benjamin Loos, Mitchell Paul Levesque, Reinhard Dummer, Christian Stockmann, Christian Münz, Johanna Diener, Lukas Sommer
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Science advances 9 (2) (2023)
Ishani Banik, Adhideb Ghosh, Erin Beebe, Blaž Burja, Mojca Frank Bertoncelj, Christopher M Dooley, Enni Markkanen, Reinhard Dummer, Elisabeth M Busch-Nentwich, Mitchell Paul Levesque
P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma. Cancers 15 (3) (2023)
S Steinmann, Carole Guillet, P F Cheng, M P Levesque, Reinhard Dummer, I Kolm, Julia-Tatjana Maul
Identifying the potential origin of mucin in primary cutaneous mucinoses - a retrospective study and analysis using histopathology and multiplex fluorescence staining. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Paolo Antonio Ascierto, Reinhard Dummer, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer, Vanna Chiarion Sileni, Caroline Dutriaux, Jan Willem B de Groot, Naoya Yamazaki, Carmen Loquai, Caroline Robert, Keith T Flaherty
Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF -Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Paolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, James M G Larkin, Georgina V Long, Rachel E Sanborn, Vanna Chiarion Sileni, Brigitte Dreno, Stéphane Dalle, Dirk Schadendorf, Margaret K Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez Roca, Naoya Yamazaki, Hussein A Tawbi, Naomey Sarkis, Deepti M Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, Jean-Jacques Grob
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nina Zila, Ossia M Eichhoff, Irene Steiner, Thomas Mohr, Andrea Bileck, Phil Fang Cheng, Alexander Leitner, Ludovic C J Gillet, Tatjana Sajic, Sandra Goetze, Betty Friedrich, Patricia Bortel, Johanna Strobl, René Reitermaier, Sabrina A Hogan, Julia Martínez Gómez, Ramon Staeger, Felix Tuchmann, Sophie Peters, Georg Stary, Mario Kuttke, Adelheid Elbe-Buerger, Christoph Hoeller, Rainer Kunstfeld, Wolfgang Weninger, Bernd Wollscheid, Reinhard Dummer, Lars Einar French, Christopher Gerner, Ruedi Aebersold, Mitchell Paul Levesque, Verena Paulitschke
Proteomic profiling of advanced melanoma patients to predict therapeutic response to anti-PD-1 therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julia Lehmann, Nicole Caduff, Ewelina Krzywińska, Salome Stierli, Adrian Salas-Bastos, Benjamin Loos, Mitchell Paul Levesque, Reinhard Dummer, Christian Stockmann, Christian Münz, Johanna Diener, Lukas Sommer
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Science advances 9 (2) (2023)
Alexander Troesch, Hoellwerth Magdalena, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F Cheng, Mitchell L Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Koelblinger Peter, Reinhard Dummer, Florentia Dimitriou
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Laura Pawlik, Sarah Morgenroth, Reinhard Dummer
Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers. Cancers 15 (6) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler, Luzia Briker, Patrick Turko, Gergely Karsai, Nina Zila, Verena Paulitschke, Phil Fang Cheng, Alexander Leitner, Andrea Bileck, Nicola Zamboni, Anja Irmisch, Zsolt Balazs, Aizhan Tastanova, Susana Pascoal, Pål Johannsen, Rebekka Wegmann, Julien Mena, Alaa Othman, Vasanthi S Viswanathan, Judith Wenzina, Andrea Aloia, Annalisa Saltari, Andreas Dzung, null null, Michael Krauthammer, Stuart L Schreiber, Thorsten Hornemann, Martin Distel, Berend Snijder, Reinhard Dummer, Mitchell Paul Levesque
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer research (2023)
Fabienne Fröhlich, Egle Ramelyte, Patrick Turko, Andreas Dzung, Sandra N Freiberger, Joanna Mangana, Mitchell Paul Levesque, Reinhard Dummer
Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma. Cancers 15 (15) (2023)
Lukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, Joanna Mangana, Phil Fang Cheng, Reinhard Dummer, Barbara Meier-Schiesser
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo Antonio Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph Hoeller, Roland Kaufmann, Celeste Lebbè, Mario Mandala, Alexander M Menzies, David Moreno, Olivier Michielin, Paul Nathan, Sapna Pradyuman Patel, Caroline Robert, Dirk Schadendorf, Paul C Lorigan, Richard A Scolyer, Hussein A Tawbi, Bart A van de Wiel, Christian U Blank, Georgina V Long
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nature medicine (2023)
Markus Haake, Beatrice Haack, Tina Schäfer, Patrick N Harter, Greta Mattavelli, Patrick Eiring, Neha Vashist, Florian Wedekink, Sabrina Genssler, Birgitt Fischer, Julia Dahlhoff, Fatemeh Mokhtari, Anastasia Kuzkina, Marij J P Welters, Tamara M Benz, Lena Sorger, Vincent Thiemann, Giovanni Almanzar, Martina Selle, Klara Thein, Jacob Späth, Maria Cecilia Gonzalez, Carmen Reitinger, Andrea Ipsen-Escobedo, Kilian Wistuba-Hamprecht, Kristin Eichler, Katharina Filipski, Pia S Zeiner, Rudi Beschorner, Renske Goedemans, Falk Hagen Gogolla, Hubert Hackl, Rogier W Rooswinkel, Alexander Thiem, Paula Romer Roche, Hemant Joshi, Dirk Pühringer, Achim Wöckel, Joachim E Diessner, Manfred Rüdiger, Eugen Leo, Phil Fang Cheng, Mitchell Paul Levesque, Matthias Goebeler, Markus Sauer, Falk Nimmerjahn, Christine Schuberth-Wagner, Stefanie von Felten, Michel Mittelbronn, Matthias Mehling, Andreas Beilhack, Sjoerd H van der Burg, Angela Riedel, Benjamin Weide, Reinhard Dummer, Jörg Wischhusen
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nature communications 14 (1) (2023)
Ishani Banik, Adhideb Ghosh, Erin Beebe, Blaž Burja, Mojca Frank Bertoncelj, Christopher M Dooley, Enni Markkanen, Reinhard Dummer, Elisabeth M Busch-Nentwich, Mitchell Paul Levesque
P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma. Cancers 15 (3) (2023)
Reinhard Dummer, Philippa Corrie, Ralf Gutzmer, Tarek M Meniawy, Michele Del Vecchio, Celeste Lebbè, Michele Guida, Caroline Dutriaux, Brigitte Dreno, Nicolas Meyer, Pier Francesco Ferrucci, Stéphane Dalle, Muhammad Adnan Khattak, Jean-Jacques Grob, Karen Briscoe, James M G Larkin, Sandrine Mansard, Thierry Lesimple, Massimo Guidoboni, Silvia Sabatini, Erika Richtig, Rudolf Herbst, Maurice Lobo, Margarita Askelson, Paolo Antonio Ascierto, Michele Maio
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Laura Pawlik, Sarah Morgenroth, Reinhard Dummer
Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers. Cancers 15 (6) (2023)
Julia Lehmann, Nicole Caduff, Ewelina Krzywińska, Salome Stierli, Adrian Salas-Bastos, Benjamin Loos, Mitchell Paul Levesque, Reinhard Dummer, Christian Stockmann, Christian Münz, Johanna Diener, Lukas Sommer
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Science advances 9 (2) (2023)
Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F Cheng, Mitchell L Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Peter Koelblinger, Reinhard Dummer, Florentia Dimitriou
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas; a retrospective cohort study from five European skin cancer reference centers. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Julia Lehmann, Nicole Caduff, Ewelina Krzywińska, Salome Stierli, Adrian Salas-Bastos, Benjamin Loos, Mitchell Paul Levesque, Reinhard Dummer, Christian Stockmann, Christian Münz, Johanna Diener, Lukas Sommer
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Science advances 9 (2) (2023)
Julia Lehmann, Nicole Caduff, Ewelina Krzywińska, Salome Stierli, Adrian Salas-Bastos, Benjamin Loos, Mitchell Paul Levesque, Reinhard Dummer, Christian Stockmann, Christian Münz, Johanna Diener, Lukas Sommer
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Science advances 9 (2) (2023)
Seungjae Lee, Ti-Cheng Chang, Patrick Schreiner, Yiping Fan, Neeraj Agarwal, Charles Owens, Reinhard Dummer, Joanne M Jeter, Raymond L Barnhill, Dan Theodorescu, Gang Wu, Armita Bahrami
Targeted Long-Read Bisulfite Sequencing Identifies Differences in the TERT Promoter Methylation Profiles between TERT Wild-Type and TERT Mutant Cancer Cells. Cancers 14 (16) (2022)
Michèle Welti, Florentia Dimitriou, Ralf Gutzmer, Reinhard Dummer
Triple Combination of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in BRAF V600 Melanoma: Current Status and Future Perspectives. Cancers 14 (22) (2022)
Anna Sophie Jahn, Alexander Andreas Navarini, Sara Elisa Cerminara, Lisa Kostner, Stephanie Marie Huber, Michael Kunz, Julia-Tatjana Maul, Reinhard Dummer, Seraina Sommer, Anja Dominique Neuner, Mitchell Paul Levesque, Phil Fang Cheng, Lara Valeska Maul
Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception. Cancers 14 (15) (2022)
Hussein A Tawbi, Caroline Robert, Jan C Brase, Daniel Gusenleitner, Eduard Gasal, James Garrett, Alexander Savchenko, Güllü Görgün, Keith T Flaherty, Antoni Ribas, Reinhard Dummer, Dirk Schadendorf, Georgina V Long, Paul D Nathan, Paolo Antonio Ascierto
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i). Journal for immunotherapy of cancer 10 (6) (2022)
Lara E Grossmann, Egle Ramelyte, Mirjam C Nägeli, Reinhard Dummer
Eight Years of Real-Life Experience with Smoothened Inhibitors in a Swiss Tertiary Skin Referral Center. Cancers 14 (10) (2022)
Funda Meric-Bernstam, Randy F Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia, Reinhard Dummer, Agostina Stradella, Georgina V Long, Anna Spreafico, Toshio Shimizu, Neeltje Steeghs, Jason John Luke, Sarah M McWhirter, Thomas Müller, Nitya Nair, Nancy Lewis, Xinhui Chen, Andrew Bean, Lisa M Kattenhorn, Marc R Pelletier, Shahneen Sandhu
Combination of the STING Agonist MIW815 and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-label, Multicenter, Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Reinhard Dummer, Keith T Flaherty, Caroline Robert, Ana M Arance, Jan Willem B de Groot, Claus Garbe, Helen J Gogas, Ralf Gutzmer, Ivana Krajsová, Gabriella Liszkay, Carmen Loquai, Mario Mandala, Dirk Schadendorf, Naoya Yamazaki, Alessandra di Pietro, Jean Cantey-Kiser, Michelle Edwards, Paolo Antonio Ascierto
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
K Schumann, C Mauch, K C Klespe, C Loquai, U Nikfarjam, M Schlaak, L Akcetin, P Kölblinger, M Hoellwerth, M Meissner, G Mengi, A D Braun, M Mengoni, Reinhard Dummer, J Mangana, M A Sindrilaru, D Radmann, C Hafner, J Freund, K Rappersberger, F Weihsengruber, F Meiss, Lydia Reinhardt, F Meier, B Rainer, E Richtig, Julia Maria Ressler, C Höller, T Eigentler, Teresa Amaral, W K Peitsch, U Hillen, W Harth, F Ziller, K Schatton, T Gambichler, L Susok, L V Maul, H Läubli, D Debus, C Weishaupt, S Börger, K Sievers, S Haferkamp, V Zenderowski, V A Nguyen, M Wanner, R Gutzmer, P Terheyden, K Kähler, S Emmert, Alexander Thiem, M Sachse, S Gercken-Riedel, K M Kaune, K M Thoms, L Heinzerling, Markus Vincent Heppt, S Tratzmiller, Wolfram Hoetzenecker, A Öllinger, A Steiner, T Peinhaupt, M Podda, S Schmid, Uwe Wollina, T Biedermann, Christian Posch
Real world outcomes using PD-1 antibodies and BRAF+MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Krisztian Homicsko, Reinhard Dummer, Christoph Hoeller, Jedd D Wolchok, F Stephen Hodi, James Larkin, Paolo Antonio Ascierto, Victoria Atkinson, Caroline Robert, Michael A Postow, Sandra Re, David Paulucci, Darin Dobler, Olivier Michielin
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma. Cancers 14 (9) (2022)
Reinhard Dummer, Georgina V Long, Caroline Robert, Hussein A Tawbi, Keith T Flaherty, Paolo Antonio Ascierto, Paul D Nathan, Piotr Lukasz Rutkowski, Oleg Leonov, Caroline Dutriaux, Mario Mandala, Paul C Lorigan, Pier Francesco Ferrucci, Jean-Jacques Grob, Nicolas Meyer, Helen J Gogas, Daniil Stroyakovskiy, Ana M Arance, Jan C Brase, Steven Green, Tomas Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Marina Tusup, Phil Fang Cheng, Ernesto Picardi, Austeja Raziunaite, Reinhard Dummer, Mitchell Paul Levesque, Lars Einar French, Emmanuella Guenova, Thomas M Kundig, Natalia Teresa Jarzebska
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7 , 5. Non-coding RNA 8 (6) (2022)
Lisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona, Julia-Tatjana Maul, Reinhard Dummer, Egle Ramelyte, Johanna Mangana, Nikolaus Benjamin Wagner, Antonio Cozzio, Saskia Kreiter, Angelika Kogler, Markus Streit, Anja Wysocki, Alfred Zippelius, Heinz Läubli, Alexander Andreas Navarini, Lara Valeska Maul
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers 14 (10) (2022)
Ken Kudura, Florentia Dimitriou, Lucas Basler, Robert Foerster, Daniela Mihic-Probst, Tim Kutzker, Reinhard Dummer, Joanna Mangana, Irene Andrea Burger, Michael C Kreissl
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13 , 3830. Cancers 14 (13) (2022)
Aurelio Boerlin, Elisa Bellini, Patrick Turko, Phil Fang Cheng, Mitchell Paul Levesque, Reinhard Dummer, Egle Ramelyte
The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. Cancers 14 (17) (2022)
Mi He, Bhavesh Soni, Petra C Schwalie, Tamara Hüsser, Caroline Waltzinger, Duvini De Silva, Ylva Prinz, Laura Krümpelmann, Samuele Calabro, Ines Matos, Christine Trumpfheller, Marina Bacac, Pablo Umaña, Mitchell P Levesque, Reinhard Dummer, Maries van den Broek, Stephan Gasser
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. Journal for immunotherapy of cancer 10 (6) (2022)
Jason A Chesney, Antoni Ribas, Georgina V Long, Joanne M Jeter, Reinhard Dummer, Igor Puzanov, Christoph Hoeller, Thomas F Gajewski, Ralf Gutzmer, Piotr Lukasz Rutkowski, Lev Demidov, Petr Arenberger, Sang Joon Shin, Pier Francesco Ferrucci, Andrew M Haydon, John R Hyngstrom, Johannes V van Thienen, Sebastian Haferkamp, Josep Malvehy Guilera, Bernardo Leon Rapoport, Ari M VanderWalde, Scott J Diede, James R Anderson, Sheryl Treichel, Edward L Chan, Sumita Bhatta, Jennifer Gansert, Frank Stephen Hodi, Helen J Gogas
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Paolo Antonio Ascierto, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen J Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Marcello Curvietto, Ignacio Melero, Giuseppe Palmieri, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Antoni Ribas, Ryan J Sullivan, Timothy Panella, Meredith A McKean, Edgardo S Santos, Kimberli Brill, Anna Polli, Alessandra di Pietro, Paolo Antonio Ascierto
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future oncology (London, England) 18 (17) (2022)
Ismael A Vergara, Christopher P Mintoff, Shahneen Sandhu, Lachlan McIntosh, Richard J Young, Stephen Q Wong, Andrew Colebatch, Daniel L Cameron, Julia Lai Kwon, Rory Wolfe, Angela Peng, Jason Ellul, Xuelin Dou, Clare Fedele, Samantha Boyle, Gisela Mir Arnau, Jeanette Raleigh, Athena Hatzimihalis, Pacman Szeto, Jennifer Mooi, Daniel S Widmer, Phil Fang Cheng, Valerie Amann, Reinhard Dummer, Nicholas K Hayward, James S Wilmott, Richard A Scolyer, Raymond J Cho, David Bowtell, Heather Thorne, Kathryn Alsop, Stephen Cordner, Noel Woodford, Jodie Leditschke, Patricia O'Brien, Sarah-Jane Dawson, Grant A McArthur, Graham J Mann, Mitchell P Levesque, Anthony T Papenfuss, Mark Shackleton
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. Nature communications 12 (1) (2021)
Ken Kudura, Florentia Dimitriou, Lucas Basler, Robert Foerster, Daniela Mihic-Probst, Tim Kutzker, Reinhard Dummer, Joanna Mangana, Irene A Burger, Michael C Kreissl
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 13 (15) (2021)
Emilie Le Rhun, Fabian Wolpert, Maud Fialek, Patrick Devos, Nicolaus Andratschke, Nicolas Reyns, Luca Regli, Reinhard Dummer, Laurent Mortier, Michael Weller
Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma. ESMO open 5 (4) (2021)
Lidija Kandolf Sekulovic, Ketty Peris, A Stratigos, A Hauschild, Ana-Maria Forsea, C Lebbe, Aimillios Lallas, Jean-Jacques Grob, C Harwood, H Gogas, P Rutkowski, J Olah, N W J Kelleners-Smeets, John Paoli, Reinhard Dummer, D Moreno-Ramirez, L Bastholt, K Putnik, R Karls, C Hoeller, V Vandersleyen, R Vieira, P Arenberger, M Bylaite-Buckinskiene, J Ocvirk, M Situm, G Weinlich, M Banjin, V Todorovic, A Ymeri, A Zhukavets, C Garbe
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (5) (2021)
Florentia Dimitriou, Ramon Staeger, Melike Ak, Matias Maissen, Ken Kudura, Marjam J Barysch, Mitchell Paul Levesque, Phil Fang Cheng, Reinhard Dummer, Joanna Mangana
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis. Cancers 13 (12) (2021)
Annalisa Saltari, Andreas Dzung, Marika Quadri, Natascia Tiso, Nicola Facchinello, Alberto Hernández-Barranco, Susana Garcia-Silva, Laura Nogués, Corinne Isabelle Stoffel, Phil Fang Cheng, Patrick Turko, Ossia M Eichhoff, Francesca Truzzi, Alessandra Marconi, Carlo Pincelli, Hector Peinado, Reinhard Dummer, Mitchell P Levesque
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression. Cancer research 81 (23) (2021)
Richard Cowan, J J Scarisbrick, P L Zinzani, J P Nicolay, L Sokol, L Pinter-Brown, Pietro Quaglino, L Iversen, Reinhard Dummer, A Musiek, F Foss, T Ito, J-P Rosen, M C Medley
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (11) (2021)
Jedd D Wolchok, Vanna Chiarion Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Lukasz Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O Butler, Andrew Hill, Ivan Marquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Celeste Lebbè, Grant A McArthur, Paolo Antonio Ascierto, Gregory A Daniels, Georgina V Long, Tuba Bas, Corey Ritchings, James M G Larkin, Frank Stephen Hodi
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Dario Simic, Reinhard Dummer, Sandra N Freiberger, Egle Ramelyte, Marjam-Jeanette Barysch
Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome. Genes 12 (5) (2021)
Clio Dessinioti, A C Geller, A Stergiopoulou, N Dimou, Serigne N Lô, U Keim, J E Gershenwald, L E Haydu, Reinhard Dummer, J Mangana, A Hauschild, F Egberts, R Vieira, A Brinca, I Zalaudek, Teresa Kränke, E Evangelou, John F Thompson, Richard A Scolyer, K Peris, Claus Garbe, A J Stratigos
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences. The British journal of dermatology 185 (1) (2021)
Sandra N Freiberger, Patrick Turko, Martin Hüllner, Reinhard Dummer, Gregoire B Morand, Mitchell Paul Levesque, David Holzmann, Niels J Rupp
Who's Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma. Cancers 13 (11) (2021)
Melike Ak, Alexandre Thiéry, Fabian M Arnold, Patrick Turko, Mitchell Paul Levesque, Martin Zoche, Egle Ramelyte, Reinhard Dummer
Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden. Genes 12 (7) (2021)
Johanna Diener, Arianna Baggiolini, Mattias Pernebrink, Damian Dalcher, Luigi Lerra, Phil Fang Cheng, Sandra Varum, Jessica Häusel, Salome Stierli, Mathias Treier, Lorenz Studer, Konrad Basler, Mitchell P Levesque, Reinhard Dummer, Raffaella Santoro, Claudio Cantú, Lukas Sommer
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4. Nature communications 12 (1) (2021)
Jürgen Wichmann, Caroline Rynn, Thomas Friess, Jeannine Petrig-Schaffland, Martin Kornacker, Cornelia Handl, Jasmin Emmenegger, Jan Eckmann, Frank Herting, Nicolas Frances, Daniel Hunziker, Daniela Krummenacher, Dominik Rüttinger, Alison Ribeiro, Marina Bacac, Alessandro Brigo, David S Hewings, Reinhard Dummer, Mitchell P Levesque, Gabriel Schnetzler, Bruno Martoglio, James R Bischoff, Piergiorgio Pettazzoni
Preclinical characterization of a next generation brain permeable, paradox breaker BRAF inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Reinhard Dummer, D E Gyorki, J Hyngstrom, A C Berger, R Conry, L Demidov, A Sharma, S A Treichel, H Radcliffe, K S Gorski, A Anderson, E Chan, M Faries, M I Ross
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial. Nature medicine 27 (10) (2021)
Mirjam Nägeli, J Mangana, K Chaloupka, Reinhard Dummer
Cutaneous SCC with orbital invasion: case series. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Reinhard Dummer, P A Ascierto, Nicole Basset-Seguin, Brigitte Dreno, Claus Garbe, R Gutzmer, A Hauschild, R Krattinger, J T Lear, J Malvehy, D Schadendorf, J J Grob
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Mirjam Nägeli, Egle Ramelyte, Reinhard Dummer
Cutaneous squamous cell carcinomas on special locations: perioral, periocular and genital area. Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Marie-Charlotte Brüggen, J Valencak, René Stranzenbach, N Li, Rudolf Stadler, C Jonak, W Bauer, S Porkert, A Blaschke, Frank Meiss, J P Nicolay, Ulrike Wehkamp, Max Schlaak, V A Nguyen, N Romani, A Cozzio, N Gayathri, F Dimitriou, L E French, Reinhard Dummer, Emmanuella Guenova
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (7) (2020)
Frédéric Toussaint, M Erdmann, E Grosch, S Schliep, G Schuler, Reinhard Dummer, L Heinzerling
Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma. The British journal of dermatology 184 (2) (2020)
M Walther, Reinhard Dummer, Laurence Imhof
Light-based therapies and scar sarcoidosis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (12) (2020)
John T Lear, Axel Hauschild, Eggert Stockfleth, Nicholas Squittieri, Nicole Basset-Seguin, Reinhard Dummer
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial. Clinical, cosmetic and investigational dermatology 13 (2020)
Reinhard Dummer, Celeste Lebbé, Victoria Atkinson, Mario Mandalà, Paul D Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A Tawbi, Paolo Antonio Ascierto, Antoni Ribas, Keith T Flaherty, Neha Pakhle, Catarina D Campbell, Daniel Gusenleitner, Aisha Masood, Jan C Brase, Eduard Gasal, Georgina V Long
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nature medicine 26 (10) (2020)
Egle Ramelyte, G Restivo, L Imhof, Mirjam Nägeli, Reinhard Dummer
How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma? The British journal of dermatology 184 (2) (2020)
Michèle Welti, Egle Ramelyte, Reinhard Dummer, Laurence Imhof
Evaluation of the minimal erythema dose for UVB and UVA in context of skin phototype and nature of photodermatosis. Photodermatology, photoimmunology & photomedicine 36 (3) (2020)
Reinhard Dummer, A Guminksi, R Gutzmer, J T Lear, K D Lewis, Anne Lynn S Chang, P Combemale, L Dirix, M Kaatz, R Kudchadkar, C Loquai, R Plummer, H-J Schulze, A J Stratigos, U Trefzer, N Squittieri, M R Migden
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. The British journal of dermatology 182 (6) (2019)
Simone M Goldinger, A Valeska Matter, U Urner-Bloch, J Narainsing, S Micaletto, I Blume, Joanna Mangana, Reinhard Dummer
Binimetinib in heavily pretreated patients with NRAS-mutant melanoma with brain metastases. The British journal of dermatology 182 (2) (2019)
Benjamin Weide, Thomas Kurt Eigentler, Chiara Catania, Paolo Antonio Ascierto, Stefano Cascinu, Jürgen Christian Becker, Axel Hauschild, Antonella Romanini, Riccardo Danielli, Reinhard Dummer, Uwe Trefzer, Giuliano Elia, Dario Neri, Claus Garbe
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients. Cancer immunology, immunotherapy : CII 68 (9) (2019)